Spot-quoted futures milestone fails to lift CME Group stock, which slips 1.21%

Spot-quoted futures milestone fails to lift CME Group stock, which slips 1.21%
CME Group slides 1.21% today

CME Group reports that its Spot-Quoted futures have reached 16 million cumulative contracts traded since launch.

Highlights

  • CME Group remains in a sustained downtrend, trading below both short- and medium-term moving averages with strong seller pressure evident.
  • Key technical support stands at $293.62 and $280.69, with immediate resistance at $305.78 and $306.74, anchoring a consolidated range.
  • Momentum and volatility indicators are broadly bearish, projecting a low probability of price recovery and a likely range between $288 and $302 next week.

The company says traders are finding new opportunities with these contracts. CME Group states that the Equity and Crypto contracts in this category are its most accessible yet.

Seller pressure below medium-term averages as long-term support holds

CME Group is trading at $295.30, currently below the SMA-20 ($303.56) and SMA-50 ($305.78), indicating sustained near- and medium-term seller pressure, while remaining well above the long-term SMA-200 ($280.69), which acts as key longer-term support. The Ichimoku Kijun at $306.74 stands above the current price, establishing immediate resistance; near-term support is seen at the EMA-100 ($293.62), with key support at the SMA-200 ($280.69), while immediate resistance is defined by the Kijun ($306.74) and the SMA-50 ($305.78).

Broadly bearish momentum as weekly price sits at range lows

Daily momentum signals are broadly bearish, with MACD on D1 issuing a Sell signal and ADX on D1 indicating weak trend strength. RSI and CCI on D1 both point to declining momentum and mild oversold conditions, echoed by Stoch RSI hovering in a neutral to oversold zone. The BBP on D1 is sharply negative, confirming that sellers currently dominate intraday action. In today's session, CME has experienced a notable decline of 1.21%. Over the week, CME has fallen $9.81 (3.22%) from the previous weekly close of $305.11, now sitting at the very bottom of its weekly range, where volatility stands at 6.34%. The price action this week reflects a persistent decline from the recent high, in line with the broader momentum indicators.

Downside favored as upside probabilities remain limited

For the coming week, the projected trading range is $288 to $302, adjusted for recent volatility and anchored around the current price, keeping well within the band defined by the 52-week low of $251.90 and high of $329.16. The probability of a price increase is very low (less than 20%), making further downside moves the more likely scenario. Baseline expectations call for CME to consolidate within the $288–$302 corridor. A bullish scenario would see a decisive move above $306.74, while a bearish outcome would be confirmed by a break below $293.62, opening room towards the SMA-200 near $280.69.

Previously it was reported that CME Group was experiencing persistent short-term bearish momentum with limited prospects for an immediate recovery. As market dynamics continue to evolve, traders should closely monitor any shifts in technical sentiment for early signs of potential trend reversal.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.